BDH Industries Limited

BDH6

INE278D01018

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-26 EDT			5-day change	1st Jan Change
367 ^INR	-1.36%		-1.81%	+67.43%

05-18	BDH Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
03-30	BDH Industries Limited Announces Directorate Changes	CI

BDH Industries Limited Recommends Dividend for the Year Ended March 31, 2023

May 17, 2023 at 10:30 am

BDH Industries Limited recommended dividend of INR 4 per equity share of the face value of INR 10 each for the year ended 31st March 2023, subject to approval of members by ordinary resolution at the upcoming Annual General Meeting.

Latest news about BDH Industries Limited

BDH Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-18	CI
BDH Industries Limited Announces Directorate Changes	03-30	CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-08	CI
BDH Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-09	CI
BDH Industries Limited Recommends Dividend for the Year Ended March 31, 2023	23-05-17	CI
BDH Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-17	CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Crisil Affirms BBB- Rating on BDH Industries' Loans; Outlook Stable	22-12-22	MT
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
BDH Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-11	CI
BDH Industries Limited Recommends Dividend for the Year Ended 31 March 2022	22-05-26	CI
BDH Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	22-05-26	CI
BDH Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-05-26	CI
BDH Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-10	CI
BDH Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-10-29	CI
BDH Industries : Crisil Affirms BBB- Rating on BDH Industries' Bank Loans; Outlook Stable	21-07-22	MT
BDH Industries' : Net Profit Climbs in Fiscal Q4	21-07-19	MT
BDH Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	21-07-19	CI
BDH Industries Limited Recommends Dividend for the Year Ended 31 March 2021	21-06-28	CI
Bdh Industries Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	21-02-09	CI
Bdh Industries Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	20-11-10	CI
Bdh Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	20-09-11	CI
Bdh Industries Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2020	20-07-21	CI
BDH Industries Limited Recommends Dividend for the Year Ended March 31, 2020	20-07-21	CI

Chart BDH Industries Limited

Duration

Period

More charts

Company Profile

BDH Industries Limited is engaged in the manufacturing of pharmaceuticals. The Company is also involved in the manufacturing of therapeutic formulations covering a range of pharmaceuticals. Its products include Analgesics, Antacids, Antibacterial, Anticoagulants, Anticonvulsants, Anti-emetics, Antifungals, Antihelmentinics, Antiasthmatic, Antimalarials, Antipsychotics and others. Its products include formulations, such as Fentanyl Citrate Injection USP, KALPANJAN Forte Pain Balm, Compound Magnesium Trisilicate Tablets BP, Alcoholic Iodine Solition BP, COLD Syrup, Dicyclomine Hydrochloride Injection, and Aciclovir Cream BP. Its manufacturing facilities consist of Oncology Division and General Pharmaceuticals. Its specialty formulations include Morphine Sulphate Slow-Release Tablets 15mg, Sulfasalazine Delayed release tablets U.S.P. 500mg, Indomethacin Extended-Release Capsules U.S.P. 75 mg and others. Its manufacturing facility is located in Mumbai.

Sector

Pharmaceuticals

Calendar

2024-08-07 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BDH INDUSTRIES LIMITED	+67.43%	25.67M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.78%	43.29B
OTSUKA HOLDINGS CO., LTD.	+27.64%	22.38B
SANDOZ GROUP AG	+19.66%	15.51B
CIPLA LIMITED	+18.68%	14.52B
ZYDUS LIFESCIENCES LIMITED	+54.64%	12.93B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-11.39%	6.56B
ASPEN PHARMACARE HOLDINGS LIMITED	+17.73%	5.87B
STADA ARZNEIMITTEL	-8.87%	5.73B